Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG

Explore clinical trials studying Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG trial results

Completed

Non-Interventional Study on the Tolerability and Efficacy of IVIG

NCT02303093

Conditions: Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
Locations: Octapharma Research Site Gmunden, Austria

Octapharma Research Site Graz, Austria

Octapharma Research Site Klagenfurt, Austria

Octapharma Research Site Oberndorf, Austria

View all 38 locations

View Trial Details